The cytogenetic effects of pyrimethamine on male mouse germ cells.
Pyrimethamine is an inhibitor of dihydrofolate reductase and is used in the treatment of malaria and toxoplasmosis. We examined the cytogenetic effects of this drug. Adult male mice were given doses of 20, 40, 80, and 120 mg/kg pyrimethamine intraperitoneally. Animals were killed by cervical dislocation on the 3rd, 6th, 9th, and 12th day after treatment, and the primary spermatocytes were harvested from their testes. These cells were analyzed for gaps, breaks, acentric fragments, and exchanges, as well as for numerical aberrations such as univalency. A dose-related increase in chromosomal aberrations was found in the pyrimethamine group compared with the control group. We suspect that pyrimethamine is a possible clastogen that may affect human germ cells.
Aydemir
N
N
Department of Biology, Faculty of Arts and Science, Uludağ University, Bursa, Turkey.
Bilaloğlu
R
R
D000818:Animals; D002869:Chromosome Aberrations / Q000139:chemically induced / Q000235:genetics* / Q000473:pathology*; D025063:Chromosome Disorders; D004249:DNA Damage; D005854:Germ Cells / Q000187:drug effects* / Q000473:pathology; D008297:Male; D051379:Mice; D009153:Mutagens / Q000633:toxicity; D011739:Pyrimethamine / Q000633:toxicity*; D013090:Spermatocytes / Q000187:drug effects / Q000473:pathology
D009153:Mutagens; D011739:Pyrimethamine